-
Mashup Score: 2CAR T-cell cancer therapies: do not forget the heart - 1 year(s) ago
This editorial refers to ‘Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients’, by S.S. Mahmood et al., https://doi.or
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Study Details Prevalence of Diastolic Dysfunction in Adults Survivors of Childhood Cancer - 1 year(s) ago
An analysis of data from the St. Jude Lifetime Cohort Study provides new insight into the risk of long-term diastolic dysfunction associated with cardiotoxic cancer therapies in adult survivors of childhood cancer.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
New research from @StJude Children's Hospital details the prevalence of diastolic dysfunction among adult survivors of childhood cancer. Learn more: https://t.co/8OzGYAsugb #Cardiology #Cardiotoxicity
-
-
Mashup Score: 0
March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics, which result in harmful effects on the heart, ultimately compromising its functional capacity. The left ventricle’s contractile ability is impaired, potentially leading to heart failure, a severe clinical outcome. Recently, a joint team of researchers from POSTECH and Georgia…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @GeorgiaInstitu A joint team of #researchers from #POSTECH and Georgia Institute of Technology successfully created an #engineered_heart via #3Dprinting technology that allows for early monitoring of drug-induced #cardiotoxicity: https://t.co/z8SNTGfOoJ
-
-
Mashup Score: 2Toxicité cardiaque de l’immunothérapie : les dernières données présentées à l’AHA 2022 - 1 year(s) ago
Tour d’horizon de la littérature et des études du congrès de l’AHA sur le diagnostic et la prise en charge des myocardites induites par l’immunothérapie.
Source: MedscapeCategories: Cardiologists, Latest HeadlinesTweet-
#CardioToxicity related to #ImmunoTherapy at #AHA2022 https://t.co/sXo8gfrzBR via @medscape
-
-
Mashup Score: 0Risk Prediction Models for Cardiotoxicity in Breast Cancer - 1 year(s) ago
This systematic review evaluates risk prediction models of cardiotoxicity for patients with breast cancer.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This systematic review assesses the evidence for use of clinical predictions models to estimate #cardiotoxicity related to chemotherapy treatment in women with breast cancer https://t.co/RoKdeLLAaH
-
-
Mashup Score: 0Getting to the Heart of Chemotherapeutic Cardiotoxicity - 1 year(s) ago
January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist, tending to patients in his cardio-oncology clinic. His schedule is packed to the brim with cancer patients. But not patients with heart cancer. The largest number of patients he sees are cancer patients who have developed, or are at risk of developing, heart damage in response to…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @UNCMedCenter Brian C. Jensen, associate professor of #medicine and #pharmacology in the Department of Medicine’s Division of #Cardiology, speaks about his research on #kinase inhibitor #cardiotoxicity: https://t.co/12w9Giag8F
-
-
Mashup Score: 3Fulminant Cardiotoxicity in a Patient With Cardiac Lymphoma Treated With CAR-T Cells - 1 year(s) ago
Author links open overlay panelUnder a Creative Commons licenseOpen accessKey WordsarrhythmiaCAR T cell therapycardiotoxicitylymphomamyocardial edemaAbbreviations and AcronymsCARchimeric antigen receptorCNScentral nervous systemCRScytokine release syndromeThe authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#Hematology Fulminant #Cardiotoxicity in a Patient With Cardiac #Lymphoma Treated With #CARTCell #CardioOnc #lymsm @JACCJournals https://t.co/emIqWejN83
-
-
Mashup Score: 14Melanoma Treatment: The Heart Has Skin in the Game∗ - 1 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Read #JACCardioOnc's editorial regrading #MEK-inhibitor based therapies and #cardiotoxicity. Great insights, but questions remain 👉 https://t.co/11Q6RtnEgT #CardioOnc #MELsm #Melanoma #CardioTwitter @SALLOUMFN
-
-
Mashup Score: 2
Abstract Background Trametinib is a MEK1 (mitogen-activated extracellular signal-related kinase kinase 1) inhibitor used in the treatment of BRAF (rapid accelerated fibrosarcoma B-type)–mutated met…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Trametinib produces a cardiomyopathy associated with elevated levels of IL-6 and oxidative stress and independent interstitial fibrosis. Learn more in #JACCCardioOnc: https://t.co/s2gGrm0Rf8 #CardioOnc #Trametinib #CardioToxicity #CardioTwitter https://t.co/tpAF4Ekic9
-
-
Mashup Score: 0
Immune checkpoint inhibitors (ICIs) have led recent advances in the field of cancer immunotherapy improving overall survival in multiple malignancies with abysmal prognoses prior to their introduction. The remarkable efficacy of ICIs is however limited by their potential for systemic and organ specific immune-related adverse events (irAEs), most of which present with mild to moderate symptoms…
Source: FrontiersCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SKCC's Dr. Credit Irabor and Dr. Bo Lu provide an updated review of the literature on the pathologic mechanisms, diagnosis, and management of autoimmune #cardiotoxicity resulting from immune checkpoint inhibitors: https://t.co/JpwfQQgql8 @FrontOncology #ResearchWednesday
-
CAR T-cell cancer therapies: do not forget the heart! https://t.co/lzMOX7r3il #cancer #CVD #therapy #CART #cardiotoxicity #cardiotwitter @escardio @ESC_Journals https://t.co/yWT2x9FKV1